For this previously recorded webinar, we partnered with Molecular Devices and Visikol to show how integrating novel 3D cell culture, tissue clearing, and high-content imaging techniques can better identify therapeutic solutions to NASH/NAFLD.
Learn how to:
•Increase assay sensitivity and viability using Primary Human Hepatocytes (PHH) pre-qualified for spheroid formation
•Apply tissue clearing techniques to fully characterize 3D cell culture models in a single workflow
•Utilize water immersion objectives and targeted acquisition with confocal imaging to fully characterize 3D fibrosis models in a high throughput manner
•Perform 3D volumetric analysis and other custom analyses for unique feature extraction and quantification